|
Q4 2018
Filed on Feb 14, 2019
|
5,583
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
10,548
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
688
|
$266.43 - $357.96
$183K - $246K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
3,234
|
$54.82 - $86.15
$177K - $279K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
3,925
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
24,815
|
N/A
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
16,341
|
$12.08 - $16.42
$197K - $268K
|
|
|
Q4 2018
Filed on Feb 14, 2019
|
84,586
|
$22.17 - $31.78
$1.88M - $2.69M
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
7,669
|
$24.77 - $31.29
$190K - $240K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
26,357
|
$2.45 - $2.96
$64.6K - $78K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
4,981
|
$26.21 - $30.65
$131K - $153K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,253
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
4,399
|
$59.7 - $69.49
$263K - $306K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
12,114
|
$18.59 - $20.4
$225K - $247K
|
|
Pimco Dynmic Credit And Mrt
|
Q3 2018
Filed on Nov 14, 2018
|
16,000
|
N/A
|
|
Achillion Pharmaceuticals In
|
Q3 2018
Filed on Nov 14, 2018
|
16,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
9,405
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
4,231
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
5,449
|
$33.03 - $39.52
$180K - $215K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
100,000
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
893
|
$135.59 - $159.33
$121K - $142K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,983
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
422
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
3,882
|
$50.15 - $54.22
$195K - $210K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
2,861
|
$69.44 - $80.52
$199K - $230K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
2,520
|
$86.17 - $100.96
$217K - $254K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
2,758
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
18,235
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
2,330
|
$46.2 - $52.15
$108K - $122K
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
21,249
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
16,111
|
N/A
|
|
|
Q3 2018
Filed on Nov 14, 2018
|
1,672
|
$127.06 - $166.78
$212K - $279K
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
13,824
|
$15.84 - $18.76
$219K - $259K
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
46,779
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
12,947
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
11,908
|
$20.96 - $26.24
$250K - $312K
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
142,753
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
113,798
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
56,950
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 14, 2018
|
7,872
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 14, 2018
|
16,799
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 14, 2018
|
31,160
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 14, 2018
|
30,492
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 14, 2018
|
63,303
|
N/A
|
|
Keryx Biopharmaceuticals Inc
|
Q2 2018
Filed on Aug 14, 2018
|
42,660
|
N/A
|
|
Claymore Exchange Trd Fd Tr
|
Q2 2018
Filed on Aug 14, 2018
|
65,137
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
19,968
|
N/A
|
|
|
Q2 2018
Filed on Aug 14, 2018
|
10,365
|
N/A
|
|
Powershares Act Mang Comm Fd
|
Q2 2018
Filed on Aug 14, 2018
|
56,129
|
N/A
|
|
Powershares Db Cmdty Idx Tra
|
Q2 2018
Filed on Aug 14, 2018
|
20,243
|
N/A
|
|